Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma

Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable...

Full description

Bibliographic Details
Main Authors: Andrea Balduit, Romana Vidergar, Paola Zacchi, Alessandro Mangogna, Chiara Agostinis, Micaela Grandolfo, Cristina Bottin, Francesco Salton, Paola Confalonieri, Andrea Rocca, Fabrizio Zanconati, Marco Confalonieri, Uday Kishore, Berhane Ghebrehiwet, Roberta Bulla
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/full
_version_ 1797813742861287424
author Andrea Balduit
Romana Vidergar
Paola Zacchi
Alessandro Mangogna
Chiara Agostinis
Micaela Grandolfo
Cristina Bottin
Francesco Salton
Paola Confalonieri
Andrea Rocca
Fabrizio Zanconati
Fabrizio Zanconati
Marco Confalonieri
Uday Kishore
Berhane Ghebrehiwet
Roberta Bulla
author_facet Andrea Balduit
Romana Vidergar
Paola Zacchi
Alessandro Mangogna
Chiara Agostinis
Micaela Grandolfo
Cristina Bottin
Francesco Salton
Paola Confalonieri
Andrea Rocca
Fabrizio Zanconati
Fabrizio Zanconati
Marco Confalonieri
Uday Kishore
Berhane Ghebrehiwet
Roberta Bulla
author_sort Andrea Balduit
collection DOAJ
description Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable of modulating HA synthesis. Thus, we investigated whether HA-C1q interaction would affect HA degradation, analyzing the main degradation enzymes, hyaluronidase (HYAL)1 and HYAL2, and a C1q receptor candidate. We first proceeded with the characterization of HYALs in MPM cells, especially HYAL2, since bioinformatics survival analysis revealed that higher HYAL2 mRNA levels have an unfavorable prognostic index in MPM patients. Interestingly, Real-Time quantitative PCR, flow cytometry and Western blot highlighted an upregulation of HYAL2 after seeding of primary MPM cells onto HA-bound C1q. In an attempt to unveil the receptors potentially involved in HA-C1q signaling, a striking co-localization between HYAL2 and globular C1q receptor/HABP1/p32 (gC1qR) was found by immunofluorescence, surface biotinylation and proximity ligation assays. RNA interference experiments revealed a potentially regulatory function exerted by gC1qR on HYAL2 expression, since C1QBP (gene for gC1qR) silencing unexpectedly caused HYAL2 downregulation. In addition, the functional blockage of gC1qR by a specific antibody hindered HA-C1q signaling and prevented HYAL2 upregulation. Thus, C1q-HA interplay is responsible for enhanced HYAL2 expression, suggesting an increased rate of HA catabolism and the release of pro-inflammatory and pro-tumorigenic HA fragments in the MPM TME. Our data support the notion of an overall tumor-promoting property of C1q. Moreover, the overlapping localization and physical interaction between HYAL2 and gC1qR suggests a potential regulatory effect of gC1qR within a putative HA-C1q macromolecular complex.
first_indexed 2024-03-13T07:56:18Z
format Article
id doaj.art-9a6b8f6959214d31bd734cc79ae1ce91
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T07:56:18Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9a6b8f6959214d31bd734cc79ae1ce912023-06-02T04:37:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.11511941151194Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesotheliomaAndrea Balduit0Romana Vidergar1Paola Zacchi2Alessandro Mangogna3Chiara Agostinis4Micaela Grandolfo5Cristina Bottin6Francesco Salton7Paola Confalonieri8Andrea Rocca9Fabrizio Zanconati10Fabrizio Zanconati11Marco Confalonieri12Uday Kishore13Berhane Ghebrehiwet14Roberta Bulla15Institute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyDepartment of Life Sciences, University of Trieste, Trieste, ItalyDepartment of Life Sciences, University of Trieste, Trieste, ItalyInstitute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyInstitute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyNeuroscience Area, International School for Advanced Studies (SISSA), Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyStruttura Complessa di Anatomia ed Istologia Patologica, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab EmiratesDepartment of Medicine, Stony Brook University, Stony Brook, NY, United StatesDepartment of Life Sciences, University of Trieste, Trieste, ItalyComplement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable of modulating HA synthesis. Thus, we investigated whether HA-C1q interaction would affect HA degradation, analyzing the main degradation enzymes, hyaluronidase (HYAL)1 and HYAL2, and a C1q receptor candidate. We first proceeded with the characterization of HYALs in MPM cells, especially HYAL2, since bioinformatics survival analysis revealed that higher HYAL2 mRNA levels have an unfavorable prognostic index in MPM patients. Interestingly, Real-Time quantitative PCR, flow cytometry and Western blot highlighted an upregulation of HYAL2 after seeding of primary MPM cells onto HA-bound C1q. In an attempt to unveil the receptors potentially involved in HA-C1q signaling, a striking co-localization between HYAL2 and globular C1q receptor/HABP1/p32 (gC1qR) was found by immunofluorescence, surface biotinylation and proximity ligation assays. RNA interference experiments revealed a potentially regulatory function exerted by gC1qR on HYAL2 expression, since C1QBP (gene for gC1qR) silencing unexpectedly caused HYAL2 downregulation. In addition, the functional blockage of gC1qR by a specific antibody hindered HA-C1q signaling and prevented HYAL2 upregulation. Thus, C1q-HA interplay is responsible for enhanced HYAL2 expression, suggesting an increased rate of HA catabolism and the release of pro-inflammatory and pro-tumorigenic HA fragments in the MPM TME. Our data support the notion of an overall tumor-promoting property of C1q. Moreover, the overlapping localization and physical interaction between HYAL2 and gC1qR suggests a potential regulatory effect of gC1qR within a putative HA-C1q macromolecular complex.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/fullhyaluronic acidhyaluronidaseC1qHYAL2gC1qR/HABP1/p32reactive oxygen species
spellingShingle Andrea Balduit
Romana Vidergar
Paola Zacchi
Alessandro Mangogna
Chiara Agostinis
Micaela Grandolfo
Cristina Bottin
Francesco Salton
Paola Confalonieri
Andrea Rocca
Fabrizio Zanconati
Fabrizio Zanconati
Marco Confalonieri
Uday Kishore
Berhane Ghebrehiwet
Roberta Bulla
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
Frontiers in Immunology
hyaluronic acid
hyaluronidase
C1q
HYAL2
gC1qR/HABP1/p32
reactive oxygen species
title Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
title_full Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
title_fullStr Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
title_full_unstemmed Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
title_short Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
title_sort complement protein c1q stimulates hyaluronic acid degradation via gc1qr habp1 p32 in malignant pleural mesothelioma
topic hyaluronic acid
hyaluronidase
C1q
HYAL2
gC1qR/HABP1/p32
reactive oxygen species
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/full
work_keys_str_mv AT andreabalduit complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT romanavidergar complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT paolazacchi complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT alessandromangogna complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT chiaraagostinis complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT micaelagrandolfo complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT cristinabottin complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT francescosalton complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT paolaconfalonieri complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT andrearocca complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT fabriziozanconati complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT fabriziozanconati complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT marcoconfalonieri complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT udaykishore complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT berhaneghebrehiwet complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma
AT robertabulla complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma